Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.9K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.9K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.4K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.4K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

952
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
952
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

547
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
547

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Listening to transform: Impact of patient experience on the improvement of an outpatient pharmacy unit.

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2026
Same journal

MAPEX-SEFH guide for the implementation of patient-reported outcomes and experience in outpatient hospital pharmacy.

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2026
Same journal

Concordance between the theoretical and real stratification of the ability-motivation-opportunity model in patients with cardiovascular pathologies.

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2026
Same journal

[Translated article] Real-world evidence of immune-related adverse events as predictive factor of response in non-small cell lung cancer.

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2026
Same journal

[Translated article] Safety of excipients in pediatric medications: impact on child health.

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2026
Same journal

[Translated article] Computerized gravimetric control of parenteral analgesic admixtures: A retrospective quality improvement study.

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2026

Related Experiment Video

Updated: Feb 3, 2026

Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

4.0K

Immunotherapy for neurological diseases, present and future.

Ricardo Constantino Ginestal-López1

  • 1Neurology Department, Hospital Universitario Fundación Jiménez Díaz UTE, Madrid. rcginestal@yahoo.es.

Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria
|November 2, 2018
PubMed
Summary

This review summarizes current immunological treatments for neurological diseases, highlighting challenges and future opportunities in immunotherapy for conditions like multiple sclerosis, Alzheimer's disease, and migraine.

More Related Videos

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.6K
A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

20.9K

Related Experiment Videos

Last Updated: Feb 3, 2026

Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

4.0K
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.6K
A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

20.9K

Area of Science:

  • Neuroimmunology
  • Neurology
  • Immunotherapy

Background:

  • A significant number of neurological diseases have an autoimmune basis, though their pathophysiology is not always fully understood.
  • Evidence supporting immunotherapies for many neurological conditions is limited, with few randomized controlled trials.
  • The landscape is rapidly evolving, with conditions like multiple sclerosis now having level 1 evidence for immunotherapy.

Purpose of the Study:

  • To provide a comprehensive summary of the immunological treatment landscape for neurological diseases.
  • To describe the current status of neuroimmunotherapy.
  • To identify future challenges and opportunities in the field of immunotherapy for neurological disorders.

Main Methods:

  • Topographical classification of autoimmune neurological pathologies.
  • Bibliographic analysis to identify relevant immunotherapeutic options.
  • Discussion of emerging neurological conditions as candidates for future immunotherapy.

Main Results:

  • Multiple sclerosis is a leading example of a neurological disease with established immunotherapy, supported by robust clinical trial evidence.
  • Prevalent conditions such as Alzheimer's disease and migraine are increasingly being considered for immunotherapy.
  • There is a growing number of neurological diseases being targeted by immunological therapies.

Conclusions:

  • The rapid expansion of immunotherapies and neurological disease candidates necessitates careful evaluation of their societal and healthcare impacts.
  • Achieving consensus among healthcare professionals is crucial for managing these complex pathologies.
  • Strategic planning is required to integrate novel neuroimmunotherapies effectively into clinical practice.